The Role of Cortisol in CNS Disease –11β-HSD1 Inhibition as a Potential New Therapeutic Strategy for Alzheimer’s Disease and Major Depressive Disorder
Preprint
- 16 October 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Cortisol is primarily synthesized by the adrenal glands, but also within specific tissues via a distinct enzymatic pathway. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyses the synthesis of cortisol within cells to create local higher cortisol environments in those organs where it is highly expressed such as the liver and brain. An extensive preclinical and clinical literature suggests that chronically, excess cortisol is detrimental. Since 11β-HSD1 expression rises with ageing, contributes to cognitive and affective disorders, and is strongly associated with Alzheimer’s disease, 11β-HSD1 inhibitors may plausibly treat cognitive and functional decline in Alzheimer’s disease and improve depression. Two inhibitors (ABT-384 and emestedastat) were studied in 12-week trials in patients with clinically diagnosed, unconfirmed Alzheimer’s disease (AD) and showed no overall benefits as a cognitive enhancer. When a subgroup with elevated blood pTau181 was later evaluated in the emestedastat trial, a slowing in progression was observed. A trial of emestedastat treatment has also reported anti-depressant activity. Thus, 11β-HSD1 inhibition appears to be a viable therapeutic mechanism. A pivotal, confirmatory trial of emestedastat treatment in 247 patients with mild-moderate AD is due to report topline results in November this year.Keywords
All Related Versions
This publication has 81 references indexed in Scilit:
- Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System DiseaseClinical Pharmacology in Drug Development, 2025
- 11-beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene expression in muscle is linked to reduced skeletal muscle index in sarcopenic patientsAging Clinical and Experimental Research, 2023
- Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterationsJournal of Endocrinological Investigation, 2023
- Cortisol hypersecretion and the risk of Alzheimer’s disease: A systematic review and meta-analysisAgeing Research Reviews, 2020
- 11β-HSD1 Inhibition Rescues SAMP8 Cognitive Impairment Induced by Metabolic StressMolecular Neurobiology, 2019
- Stress and aging act through common mechanisms to elicit neuroinflammatory primingBrain, Behavior, and Immunity, 2018
- 11β-HSD1 Inhibition by RL-118 Promotes Autophagy and Correlates with Reduced Oxidative Stress and Inflammation, Enhancing Cognitive Performance in SAMP8 Mouse ModelMolecular Neurobiology, 2018
- Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorderDepression and Anxiety, 2010
- Metyrapone as Additive Treatment in Major DepressionArchives of General Psychiatry, 2004
- Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neuronsBrain Research, 1990